eli lilly new glp 1 The Food and Drug Administration has approved the first oral GLP-1 weight loss drug by Lilly, called Foundayo Eli Lilly's GLP-1 pill that

We thank Drs Brian Sweatman and John Haselden of GlaxoSmithKline, Ware, UK for generous access to high-resolution NMR facilities

Invega Sustenna/Xeplion/Invega Trinza/Trevicta (paliperidone) Disease area(s): Psychiatry Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $4.22 billion Why it sold so well: In 2024, J&Js long-acting antipsychotic portfolio including Invega Sustenna, Xeplion, Invega Trinza and Trevicta registered global sales of $4.22 billion, reflecting a 2.6% year-over-year increase

C.ChandranP.SalyersA

Federal Ozempic vision loss lawsuits and gastrointestinal injury cases have been consolidated into multidistrict litigation in the Eastern District of Pennsylvania, where plaintiffs allege the manufacturers minimized or delayed warnings about these severe injuries despite emerging safety reports and adverse event data

A potentially higher occupational risk has been described for several other solid tumors (390)